Unilever PLC (LSE:ULVR) notes recent reporting regarding its interest in GlaxoSmithKline plc (LSE:GSK)'s Consumer Healthcare and confirms that it has approached GSK and Pfizer Inc. (NYSE:PFE) about a potential acquisition of the business. GSK Consumer Healthcare is a leader in the attractive consumer health space and would be a strong strategic fit as Unilever continues to re-shape its portfolio. There can be no certainty that any agreement will be reached.
Market Closed -
Other stock markets
|
After market 05:30:00 am | |||
27.8 USD | +1.39% |
|
27.74 | -0.20% |
27/06 | Pfizer, BioNTech Get Positive Committee Opinion for Omicron JN.1-Adapted COVID-19 Vaccine in European Union | MT |
27/06 | Pfizer, BioNTech Get Positive CHMP Opinion for New Covid-19 Vaccine | DJ |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
4,377 GBX | -0.97% | -1.26% | 14TCr | ||
1,526 GBX | -4.60% | -5.69% | 7.87TCr | ||
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.44% | 16TCr | |
+55.95% | 82TCr | |
+43.62% | 64TCr | |
-6.98% | 35TCr | |
+19.08% | 33TCr | |
+9.05% | 30TCr | |
+16.30% | 24TCr | |
+2.41% | 23TCr | |
+12.47% | 22TCr | |
+8.91% | 17TCr |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Unilever Reports Interest in Acquiring GSK Consumer Healthcare